We explain the science behind the headlines on dementia blood tests, what they are and who can benefit. And whether they can ...

Frontotemporal dementia also called FTD, is a rarer type of dementia caused by a build up of proteins, tau, FUS and TDP-43, in the frontal and temporal lobes of the brain. Dementia is caused by ...

There are several rarer conditions that can lead to dementia or dementia-like symptoms. Around 35,000 people in the UK are thought to be affected by these rarer causes of dementia. Dementia is not a ...

Join us on Monday 24 February 2025, for a day dedicated to supporting early career researchers in the dementia field. Sessions start at 11am. This event is designed to provide you with the knowledge, ...

The Dementia Community Champions play a key role in our mission to promote a better understanding of dementia and brain ...

Early and accurate diagnosis is the cornerstone of effective, person-centred care – and nowhere is this more important than in dementia. Spotting the signs early and getting a diagnosis can change ...

New research studying records of over 300,000 people suggests a link between herpes simplex virus-1 infection and Alzheimer's ...

Marian and Geoff have taken part in clinical trials to test new treatments for Alzheimer’s disease. With new dementia ...

Hundreds of walkers came together in Leeds to kick-off this year’s Walk For A Cure series. The walk at Harewood House saw ...

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

People with early-stage Alzheimer’s disease in Scotland will not be able to access the drug donanemab on the NHS, after it was rejected for use by the Scottish Medicines Consortium (SMC). Donanemab is ...